Category Archives: Drug prices

The Drug Pricing Conundrum: Why Transparency Reforms Are Necessary to Make Healthcare Accessible

Source: News 18 26th August, 2019   While an intellectual property system that includes safeguards for early introduction of generics does reap price-lowering benefits for India, making transparency reforms part of its agenda will spotlight the mark-ups, production costs and the … Continue reading

Posted in Drug prices, Transparency | Leave a comment

Drug Prices Can Take A Surprising Turn When A Poor Country Gets Richer

Source: National Public Radio 9th July, 2019       When a poor country becomes wealthier, it’s a good thing, right? Not if the country is trying to buy essential medicines. A new report, published by the Center for Global Development in … Continue reading

Posted in Drug prices | Leave a comment

Drug price promise ‘falter’

Source: Telegraph India 28th June, 2019   Cryptococcal meningitis kills an estimated 180,000 people every year, over three-fourths of them in sub-Saharan Africa Pathogenic yeast fungus Cryptococcus neoformans causes meningoencephalitis in patients with AIDS.(Shutterstock: 3D illustration) The US-based pharmaceutical company Gilead … Continue reading

Posted in Drug prices | Leave a comment

Gilead’s HIV drug remains costly despite the company’s promise to slash its price

Source: The Hindu Business Line 28th June, 2019   Government force to opt for cheaper medicines with side-effects, says MSF US pharmaceutical firm Gilead is not living up to its promise of supplying the life-saving anti-fungal drug liposomal amphotericin B (LAmB) … Continue reading

Posted in Drug prices, HIV/Aids | Leave a comment

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

Source: Reuters 25th June, 2019   NEW YORK (Reuters) – Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices … Continue reading

Posted in Drug prices | Leave a comment

Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution

Source: Health Policy Watch 27th May, 2019   The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition … Continue reading

Posted in Drug prices, R&D | Leave a comment

Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure

Source: Health Policy Watch 27th May, 2019   After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices … Continue reading

Posted in Drug prices | Leave a comment